Ropharma only bought back 2.8 million shares (0.5495%), for which it paid 1.04 million lei (EUR0.23 million).
The buyback program unfolded between May 5 and May 26.
Ropharma reported a first quarter net profit of RON2.8 million, up 6% on the year. Its sales fell 2% to RON102.5 million.
The company is 31.65%-owned by Romanian entrepreneur Mihai Miron, while U.S. Arrow Pharmaceuticals holds a 31.29% stake.
Arrow Pharmaceuticals, firmă înregistrată în SUA, controlează 31,29% din acțiunile Ropharma.
Monday, Ropharma closed flat at RON0.36 a share in Bucharest. (EUR1=RON4.3919)